| MECP2 |
MECP2: Methyl-CpG-binding protein 2 |
HDAC4 |
HDAC4, KIAA0288: Histone deacetylase 4 |
0.265 |
Evidence |
|
| BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
WRN |
WRN, RECQ3, RECQL2: Werner syndrome ATP-dependent helicase |
0.265 |
Evidence |
|
| BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
YBX1 |
YBX1, NSEP1, YB1: Nuclease sensitive element-binding protein 1 |
0.265 |
Evidence |
|
| SMARCA4 |
SMARCA4, BRG1, SNF2B, SNF2L4: Probable global transcription activator SNF2L4 |
IRF3 |
IRF3: Interferon regulatory factor 3 |
0.265 |
Evidence |
|
| SMARCA4 |
SMARCA4, BRG1, SNF2B, SNF2L4: Probable global transcription activator SNF2L4 |
TOP3A |
TOP3A, TOP3: DNA topoisomerase 3-alpha |
0.265 |
Evidence |
|
| SMARCA4 |
SMARCA4, BRG1, SNF2B, SNF2L4: Probable global transcription activator SNF2L4 |
EIF4G1 |
EIF4G1, EIF4F, EIF4G, EIF4GI: Eukaryotic translation initiation factor 4 gamma 1 |
0.265 |
Evidence |
|
| SMARCA4 |
SMARCA4, BRG1, SNF2B, SNF2L4: Probable global transcription activator SNF2L4 |
HSF2 |
HSF2, HSTF2: Heat shock factor protein 2 |
0.265 |
Evidence |
|
| DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
HSPB8 |
HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 |
0.265 |
Evidence |
|
| DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
CDK5 |
CDK5: Cell division protein kinase 5 |
0.265 |
Evidence |
|
| CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
0.265 |
Evidence |
|
| VASP |
VASP: Vasodilator-stimulated phosphoprotein |
FNBP1 |
IPI00102670 |
0.265 |
Evidence |
|
| VASP |
VASP: Vasodilator-stimulated phosphoprotein |
JAK1 |
|
0.265 |
Evidence |
|
| VASP |
VASP: Vasodilator-stimulated phosphoprotein |
DYNC1LI1 |
DYNC1LI1, DNCLI1: Cytoplasmic dynein 1 light intermediate chain 1 |
0.265 |
Evidence |
|
| VASP |
VASP: Vasodilator-stimulated phosphoprotein |
STK24 |
STK24, MST3, STK3: Serine/threonine-protein kinase 24 |
0.265 |
Evidence |
|
| VASP |
VASP: Vasodilator-stimulated phosphoprotein |
STK38L |
STK38L, KIAA0965, NDR2: Serine/threonine-protein kinase 38-like |
0.265 |
Evidence |
|
| VASP |
VASP: Vasodilator-stimulated phosphoprotein |
NRBP1 |
NRBP1, BCON3, NRBP: Nuclear receptor-binding protein |
0.265 |
Evidence |
|
| VASP |
VASP: Vasodilator-stimulated phosphoprotein |
TBK1 |
TBK1, NAK: Serine/threonine-protein kinase TBK1 |
0.265 |
Evidence |
|
| VASP |
VASP: Vasodilator-stimulated phosphoprotein |
TAOK3 |
TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 |
0.265 |
Evidence |
|
| VASP |
VASP: Vasodilator-stimulated phosphoprotein |
PRKD2 |
PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 |
0.265 |
Evidence |
|
| VASP |
VASP: Vasodilator-stimulated phosphoprotein |
MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
0.265 |
Evidence |
|
| VASP |
VASP: Vasodilator-stimulated phosphoprotein |
NEK7 |
NEK7: Serine/threonine-protein kinase Nek7 |
0.265 |
Evidence |
|
| VASP |
VASP: Vasodilator-stimulated phosphoprotein |
ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
0.265 |
Evidence |
|
| VASP |
VASP: Vasodilator-stimulated phosphoprotein |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
0.265 |
Evidence |
|
| TAF6 |
TAF6, TAF2E, TAFII70: Transcription initiation factor TFIID subunit 6 |
PTMA |
IPI00015550 |
0.265 |
Evidence |
|
| TAF6 |
TAF6, TAF2E, TAFII70: Transcription initiation factor TFIID subunit 6 |
GNB2L1 |
Lung cancer oncogene 7 |
0.265 |
Evidence |
|